Rare diseases
Investigational molecules
Locations
Back to Italy153 clinical trials in Messina, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy
ItalyStudy of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease
ItalyStudy on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma
ItalyStudy on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms
ItalyStudy on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
ItalyStudy on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease
ItalyStudy on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease
ItalyStudy on Early Drug Withdrawal in Children with Juvenile Idiopathic Arthritis Using Secukinumab and Drug Combination for Those in Clinical Remission
ItalyStudy of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn's Disease
ItalyStudy of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
ItalyEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
ItalyPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and lung cancer treatments.
Research emphasizes targeted therapies and immunotherapy combinations for improved patient outcomes.
Clinical studies investigating treatments for Crohn's disease, ulcerative colitis, and pyoderma gangrenosum, focusing on novel therapeutic approaches.
Emphasis on developing targeted biological therapies for chronic inflammatory conditions.
Groundbreaking research on Rett Syndrome, transthyretin amyloidosis, and polycystic kidney disease, exploring innovative treatment options.
Focus on developing targeted treatments for rare genetic conditions and improving patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
